Published in Digestive diseases and sciences
Post-lung transplant exposure to persistent PPI therapy results in the greatest protection against rejection in lung transplant recipients, independent of other clinical predictors including BMI, suggesting that PPI may have antireflux or anti-inflammatory effects in enhancing allograft protection.
Published in Digestive diseases and sciences
SIBO was found to be associated with CAD and with the number of coronary arteries involved in this study from a single tertiary center. Further studies are necessary to confirm the association of SIBO with CAD. In the presence of risk factors, patients with SIBO may benefit from assessment for CAD.
Published in Digestive diseases and sciences
Food allergy, a commonly increasing problem worldwide, defined as an adverse immune response to food. A variety of immune-related effector cells such as mast cells, eosinophils, neutrophils, and T cells are involved in food-related allergic responses categorized as IgE mediated, non-IgE mediated, and mixed (IgE and non-IgE) depending upon underlyin...
Published in Digestive diseases and sciences
Overall findings indicate that some adipokines may play a crucial role in IBD severity or other IBD related outcomes. Further studies are recommended to confirm the results.
Published in Digestive diseases and sciences
Published in Digestive diseases and sciences
Gastric perfusion with capsaicin does not directly influence rectal physiology through a reflex arc.
Published in Digestive diseases and sciences
Our data showed that ERRα can trigger the proliferation and migration of CRC cells via up regulation of IL-8. Therefor targeted inhibition of ERRα/IL-8 might be a potential approach for CRC treatment and drug development.
Published in Digestive diseases and sciences
Our study objectively demonstrates significant association of ESAP and early mortality with primary cytokine response, and development of IPN with persistent HLA-DR down-regulation.
Published in Digestive diseases and sciences
Published in Digestive diseases and sciences
The gastrointestinal tract may contain sites of action regulating MS reduction by PYY 3-36.
